Turnbull, Andrew V., and Catherine L. Rivier. Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action. Physiol. Rev. 79: 1–71, 1999. — Glucocorticoids a...

Regulation of the Hypothalamic-Pituitary-Adrenal Axis by Cytokines: Actions and Mechanisms of Action

Leptin enters the brain by a saturable system independent of insulin.

Transport of brain-derived neurotrophic factor across the blood-brain barrier

/pdf/inflammation-as-a-central-mechanism-in-alzheimer-s-disease-eiiqrx1far.pdf

Inflammation as a central mechanism in Alzheimer's disease

▪ Abstract The interleukin-1 receptor antagonist (IL-1Ra) is a member of the IL-1 family that binds to IL-1 receptors but does not induce any intracellular response. Two structural variants of IL-1Ra have previously been described: a 17-kDa form that is secreted from monocytes, macrophages, neutrophils, and other cells (sIL-1Ra) and an 18-kDa form that remains in the cytoplasm of keratinocytes and other epithelial cells, monocytes, and fibroblasts (icIL-1Ra). An additional 16-kDa intracellular isoform of IL-1Ra has recently been described in neutrophils, monocytes, and hepatic cells. Both of the major isoforms of IL-1Ra are transcribed from the same gene through the use of alternative first exons. The two promoters regulating transcription of the secreted and intracellular forms have been cloned, and some of the functional cis-acting DNA regions have been characterized. The production of IL-1Ra is stimulated by many substances including adherent IgG, other cytokines, and bacterial or viral components. The...

INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology

Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

Penetration of interleukin-6 across the murine blood-brain barrier.

Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier

Impairment of the blood-brain barrier (BBB) in experimental autoimmune encephalomyelitis (EAE) has been frequently attributed to disruption, without much consideration of saturable transport processes. In mice with EAE, we studied the permeability of the BBB to radioactively labeled albumin and sucrose, markers of BBB disruption, and tumor necrosis factor-alpha (TNF-alpha), a cytokine transported across the BBB by a saturable system and thought to play a role in the pathogenesis of EAE. Permeation of the BBB was increased to all three substances during the acutely ill stage, was greatest in the lumbar spine, and returned to normal with recovery. The change in BBB permeability to sucrose was greater than to the larger albumin and is consistent with a partial disruption of the BBB. The enhanced permeability to TNF-alpha was comparable to that for sucrose, even though TNF-alpha is similar in size to albumin. This paradoxically high uptake of TNF-alpha could be explained by an enhancement of its endogenous saturable transport system. Thus the changes in BBB function during EAE extend beyond disruption to include changes in the saturable transport systems for substances involved in the disease process.

Enrique G. Gutierrez

Papers

Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

Penetration of interleukin-6 across the murine blood-brain barrier.

Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier

Differential permeability of the BBB in acute EAE: enhanced transport of TNT-alpha

Interleukin-1α in blood has direct access to cortical brain cells